Antiretroviral initiation during or following treatment of TB

An open-label, randomized, controlled trial of early vs. delayed initiation of HAART was conducted in 642 patients with active TB and HIV infection in Durban, South Africa.

Saved in:
Bibliographic Details
Published inAIDS Alert Vol. 25; no. 6; pp. 69 - 70
Main Author Winslow, Dean L
Format Journal Article Trade Publication Article
LanguageEnglish
Published United States Relias Learning 01.06.2010
Subjects
AIDS-Related Opportunistic Infections - drug therapy
AIDS/HIV
Antiretroviral drugs
Antiretroviral Therapy, Highly Active
Antitubercular Agents - therapeutic use
Clinical medicine
Drug therapy
HIV
HIV Infections - complications
HIV Infections - drug therapy
Human immunodeficiency virus
Humans
Randomized Controlled Trials as Topic
Tuberculosis - complications
Tuberculosis - drug therapy
Online AccessGet full text

Cover

More Information
Summary:An open-label, randomized, controlled trial of early vs. delayed initiation of HAART was conducted in 642 patients with active TB and HIV infection in Durban, South Africa.
Bibliography:SourceType-Other Sources-1
ObjectType-News-1
content type line 66
ISSN:0887-0292